Literature DB >> 34849954

A multi-scale/multi-physics model for the theoretical study of the vascular configuration of retinal capillary plexuses based on OCTA data.

Greta Chiaravalli1,2, Giovanna Guidoboni3, Riccardo Sacco4, Jake Radell5, Alon Harris5.   

Abstract

The retinal tissue is highly metabolically active and is responsible for translating the visual stimuli into electrical signals to be delivered to the brain. A complex vascular structure ensures an adequate supply of blood and oxygen, which is essential for the function and survival of the retinal tissue. To date, a complete understanding of the configuration of the retinal vascular structures is still lacking. Optical coherence tomography angiography has made available a huge amount of imaging data regarding the main retinal capillary plexuses, namely the superficial capillary plexuses (SCP), intermediate capillary plexuses (ICP) and deep capillary plexuses (DCP). However, the interpretation of these data is still controversial. In particular, the question of whether the three capillary plexuses are connected in series or in parallel remains a matter of debate. In this work, we address this question by utilizing a multi-scale/multi-physics mathematical model to quantify the impact of the two hypothesized vascular configurations on retinal hemodynamics and oxygenation. The response to central retinal vein occlusion (CRVO) and intraocular pressure (IOP) elevation is also simulated depending on whether the capillary plexuses are connected in series or in parallel. The simulation results show the following: (i) in the in series configuration, the plexuses exhibit a differential response, with DCP and ICP experiencing larger pressure drops than SCP; and (ii) in the in parallel configuration, the blood flow redistributes uniformly in the three plexuses. The different vascular configurations show different responses also in terms of oxygen profiles: (i) in the in series configuration, the outer nuclear layer, outer plexiform layer and inner nuclear layer (INL) are those most affected by CRVO and IOP elevation; and (ii) in the in parallel configuration the INL and ganglion cell layer are those most affected. The in series results are consistent with studies on paracentral acute middle maculopathy, secondary to CRVO and with studies on IOP elevation, in which DCP and ICP and the retinal tissues surrounding them are those most affected by ischemia. These findings seem to suggest that the in series configuration better describes the physiology of the vascular retinal capillary network in health and disease.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Institute of Mathematics and its Applications. All rights reserved.

Entities:  

Keywords:  capillary plexuses; central retinal vein occlusion; intraocular pressure elevation; optical coherence tomography angiography; oxygenation; retina; vascularization

Mesh:

Substances:

Year:  2022        PMID: 34849954      PMCID: PMC8906920          DOI: 10.1093/imammb/dqab018

Source DB:  PubMed          Journal:  Math Med Biol        ISSN: 1477-8599            Impact factor:   1.854


  26 in total

Review 1.  Paracentral Acute Middle Maculopathy: What We Knew Then and What We Know Now.

Authors:  Ehsan Rahimy; Laura Kuehlewein; Srinivas R Sadda; David Sarraf
Journal:  Retina       Date:  2015-10       Impact factor: 4.256

2.  Diameters of retinal blood vessels in a healthy cohort as measured by spectral domain optical coherence tomography.

Authors:  Dafna Goldenberg; Jonathan Shahar; Anat Loewenstein; Michaella Goldstein
Journal:  Retina       Date:  2013-10       Impact factor: 4.256

3.  Three-Dimensional Microscopy Demonstrates Series and Parallel Organization of Human Peripapillary Capillary Plexuses.

Authors:  Erandi Chandrasekera; Dong An; Ian L McAllister; Dao-Yi Yu; Chandrakumar Balaratnasingam
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-09-04       Impact factor: 4.799

4.  Effect of intraocular pressure on the hemodynamics of the central retinal artery: a mathematical model.

Authors:  Giovanna Guidoboni; Alon Harris; Lucia Carichino; Yoel Arieli; Brent A Siesky
Journal:  Math Biosci Eng       Date:  2014-06       Impact factor: 2.080

5.  Intraocular pressure, blood pressure, and retinal blood flow autoregulation: a mathematical model to clarify their relationship and clinical relevance.

Authors:  Giovanna Guidoboni; Alon Harris; Simone Cassani; Julia Arciero; Brent Siesky; Annahita Amireskandari; Leslie Tobe; Patrick Egan; Ingrida Januleviciene; Joshua Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-29       Impact factor: 4.799

6.  Estimation of oxygen distribution in RIF-1 tumors by diffusion model-based interpretation of pimonidazole hypoxia and eppendorf measurements.

Authors:  B W Pogue; K D Paulsen; J A O'Hara; C M Wilmot; H M Swartz
Journal:  Radiat Res       Date:  2001-01       Impact factor: 2.841

Review 7.  Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease.

Authors:  D Y Yu; S J Cringle
Journal:  Prog Retin Eye Res       Date:  2001-03       Impact factor: 21.198

8.  Oxygen distribution and consumption in the cat retina during normoxia and hypoxemia.

Authors:  R A Linsenmeier; R D Braun
Journal:  J Gen Physiol       Date:  1992-02       Impact factor: 4.086

9.  Retinal Capillary Plexus Pattern and Density from Fovea to Periphery Measured in Healthy Eyes with Swept-Source Optical Coherence Tomography Angiography.

Authors:  Carlo Lavia; Pedro Mecê; Marco Nassisi; Sophie Bonnin; Jennifer Marie-Louise; Aude Couturier; Ali Erginay; Ramin Tadayoni; Alain Gaudric
Journal:  Sci Rep       Date:  2020-01-30       Impact factor: 4.379

10.  Volume Rendering of Dense B-Scan Optical Coherence Tomography Angiography to Evaluate the Connectivity of Macular Blood Flow.

Authors:  Diogo Cabral; Telmo Pereira; Gerardo Ledesma-Gil; Catarina Rodrigues; Florence Coscas; David Sarraf; K Bailey Freund
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.